Effects of yohimbine and hydrocortisone on panic symptoms, autonomic responses, and attention to threat in healthy adults.
BACKGROUND
Research in rodents and non-human primates implicates the noradrenergic system and hypothalamic-pituitary-adrenal axis in stress, anxiety, and attention to threat. Few studies examine how these two neurochemical systems interact to influence anxiety and attention in humans.


OBJECTIVE
The objective of this paper is to examine the effects of exogenous yohimbine and hydrocortisone, as well as their combination (Y + H), on panic symptoms and attention to social threat cues.


METHODS
Thirty-two healthy adults underwent a pharmacological challenge in which they were blindly randomized to either yohimbine, hydrocortisone, Y + H, or placebo. Thirty minutes after drug infusion, attention to threat was measured using the dot probe task, a visual attention task that presents angry, happy, and neutral faces and measures the degree of attention allocated towards or away from the emotional faces. Panic and autonomic measures were assessed before and 30 min after drug infusion.


RESULTS
There was a significant increase in panic symptoms in the yohimbine and Y + H groups, but not in the hydrocortisone or placebo groups. Yohimbine resulted in a greater increase in panic symptoms than Y + H. On the dot probe task, the placebo group exhibited an attention bias to angry faces, whereas this bias was absent after yohimbine. When collapsing across groups, increased panic symptoms was associated with less attention to angry faces.


CONCLUSIONS
Exogenous hydrocortisone may attenuate noradrenergic-induced panic symptoms. The inverse relationship between panic symptoms and attention to angry faces extends prior research demonstrating attention modulation by stressful conditions.
Vasa
Roma A
RA
Department of Psychiatry, Kennedy Krieger Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21211, USA. vasa@kennedykrieger.org
Pine
Daniel S
DS
Masten
Carrie L
CL
Vythilingam
Meena
M
Collin
Carlos
C
Charney
Dennis S
DS
Neumeister
Alexander
A
Mogg
Karin
K
Bradley
Brendan P
BP
Bruck
Maggie
M
Monk
Christopher S
CS
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000786:Anger; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001288:Attention / Q000187:drug effects; D001341:Autonomic Nervous System / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects; D003463:Cues; D004311:Double-Blind Method; D005149:Facial Expression; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use*; D008297:Male; D016584:Panic Disorder / Q000188:drug therapy* / Q000523:psychology*; D015016:Yohimbine / Q000627:therapeutic use*; D055815:Young Adult
D000317:Adrenergic alpha-Antagonists; D000893:Anti-Inflammatory Agents; D015016:Yohimbine; D006854:Hydrocortisone